NRG
50
-2
VZ
42
3
BA
45
-3
DLTR
40
4
HUM
48
2
PCG
99
2
RRC
60
-3
STI
31
19
EFX
41
-2
UNH
63
-2
VNO
60
8
UPS
50
9
DFS
67
-3
TXN
49
-6
DOV
73
4
NWS
79
-4
PM
58
2
PG
50
2
WDC
38
-3
DG
12
2
NRG
50
-2
VZ
42
3
BA
45
-3
DLTR
40
4
HUM
48
2
PCG
99
2
RRC
60
-3
STI
31
19
EFX
41
-2
UNH
63
-2
VNO
60
8
UPS
50
9
DFS
67
-3
TXN
49
-6
DOV
73
4
NWS
79
-4
PM
58
2
PG
50
2
WDC
38
-3
DG
12
2
Financhill
Back

Verrica Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
0.87
Seasonality Move:
34.27%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump wins! Dow to 75,000? Details here

See the explosive "Document 20" details here.

Verrica Pharmaceuticals Price Quote

$0.87
+0.03 (+3.2%)
(Updated: November 14, 2024 at 5:10 PM ET)

Verrica Pharmaceuticals Key Stats

Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell
Day range:
$0.83 - $0.93
52-week range:
$0.70 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.67
P/B ratio:
0%
Volume:
342K
Avg. volume:
1.1M
1-year change:
-71.99%
Market cap:
$42.2M
Revenue:
$5.1M
EPS:
$-1.84

How Much Does Verrica Pharmaceuticals Make?

Is Verrica Pharmaceuticals Growing As A Company?

Data Unavailable

Verrica Pharmaceuticals Stock Price Performance

What Is Verrica Pharmaceuticals 52-Week High & Low?

Verrica Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Verrica Pharmaceuticals?

Is Verrica Pharmaceuticals Cash Flow Positive?

  • What Is VRCA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$59.4M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.7M
  • What Is Verrica Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$254K

Verrica Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    VRCA return on invested capital is -184.44%
  • What Is Verrica Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -128.78%
  • What Is VRCA Return On Equity?
    ROE is a measure of profitability and is -2619.46%

Verrica Pharmaceuticals Earnings Date & Stock Price

Verrica Pharmaceuticals Competitors

Verrica Pharmaceuticals Dividend Yield

Verrica Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -26.45%
Revenue: 0% -133.85%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 4
Sell Recommendations: 0
Price Target: 6.33
Upside from Last Price: 651.28%

Major Shareholders

  • How many VRCA shares are owned by institutional investors?
    26.7M VRCA shares are owned by institutional investors
  • How many VRCA shares are owned by insiders?
    11.7M VRCA shares are owned by insiders